MIF4GD anticorps (Isoform 1, N-Term)
-
- Antigène Voir toutes MIF4GD Anticorps
- MIF4GD (MIF4G Domain Containing (MIF4GD))
-
Épitope
- Isoform 1, N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MIF4GD est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Reacts with human MIF4GD protein, isoform 1
- Purification
- Purified (protein A)
- Immunogène
- Synthetic peptide derived from N terminal part of human MIF4GD protein, isoform 1.
- Top Product
- Discover our top product MIF4GD Anticorps primaire
-
-
- Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only :
- WB : 1/100 to 1/2000 - Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Must be reconstituted in distilled water.
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Date de péremption
- 24 months
-
- Antigène
- MIF4GD (MIF4G Domain Containing (MIF4GD))
- Autre désignation
- MIF4G Domain-Containing Protein (MIF4GD Produits)
- Synonymes
- anticorps AD023, anticorps MIFD, anticorps SLIP1, anticorps 1110014L05Rik, anticorps 2310075G12Rik, anticorps RGD1309685, anticorps MIF4GD, anticorps zgc:64152, anticorps zgc:110826, anticorps ad023, anticorps mif4gd, anticorps mif4gd-a, anticorps mif4gd-b, anticorps mifd, anticorps slip1, anticorps MIF4G domain containing, anticorps MIF4G domain containing a, anticorps MIF4G domain containing b, anticorps MIF4G domain containing L homeolog, anticorps MIF4G domain containing S homeolog, anticorps MIF4GD, anticorps Mif4gd, anticorps mif4gda, anticorps mif4gdb, anticorps mif4gd.L, anticorps mif4gd.S
- Sujet
- Belongs to the MIF4GD family. Functions in replication-dependent translation of histone mRNAs which differ from other eukaryotic mRNAs in that they do not end with a poly-A tail but a stem-loop. May participate in circularizing those mRNAs specifically enhancing their translation. Interacts with EIF4G1, EIF4G2 and SLBP.
-